David Spellman
Geen lopende functies
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van David Spellman
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 13 | |
| Public Company | Biotechnology | 8 | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.
4
| Private Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David Spellman via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Comptroller/Controller/Auditor General Counsel | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President Corporate Officer/Principal | |
| MERUS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor General Counsel | |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| University of Virginia | College/University | Graduate Degree | |
| ALDEYRA THERAPEUTICS, INC. | Biotechnology | General Counsel | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Therachon SAS
 Therachon SAS BiotechnologyHealth Technology TherAchon SAS provides biotechnology services. It specializes in research and development for achondroplasia and its associated complications. The company was founded by Elvire Gouze in 2014 and is headquartered in Biot, France. | Biotechnology | Director/Board Member | |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | Director/Board Member | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | General Counsel | |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal | |
Tiburio Therapeutics, Inc.
 Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
New England Venture Capital Association, Inc.
 New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Avoro Ventures LLC
 Avoro Ventures LLC Investment ManagersFinance Avoro Ventures LLC (Avoro Ventures) is a venture capital subsidiary of Avoro Capital Advisor LLC founded in 2020. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Cydan LLC
 Cydan LLC Medical DistributorsDistribution Services Cydan LLC operates as an orphan drug accelerator that identifies and de-risks programs. The firm's model evaluates programs for treating rare diseases with unmet medical need and is aimed at creating new companies to develop those therapies. The company was founded by James G. McArthur in 2013 and is headquartered in Cambridge, MA. | Medical Distributors | Director/Board Member | |
| ADEIA INC. | Semiconductors | Director/Board Member | |
Enavate Sciences
 Enavate Sciences Financial ConglomeratesFinance Enavate Sciences is a platform created by Patient Square Capital to support therapeutic companies in advancing medicines and enabling technologies to address patient needs. The company is based in Delaware. Enavate strives to empower a diverse portfolio of therapeutic companies to accelerate innovation through capital support and operational experience. James P. Boylan has been the CEO of the American company since 2022. | Financial Conglomerates | President | |
| VERENIUM CORP | Biotechnology | Investor Relations Contact | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| VIGIL NEUROSCIENCE, INC. | Biotechnology | Investor Relations Contact | |
| Rochester Christian University | College/University | Undergraduate Degree | |
| Wyeth-Ayerst Research | General Counsel | ||
Wilson Elser Moskowitz Edelman & Dicker LLP
 Wilson Elser Moskowitz Edelman & Dicker LLP Miscellaneous Commercial ServicesCommercial Services Wilson, Elser, Moscowitz, Edelman & Decker LLP provides legal services. It offers litigation, business and financial, insurance and reinsurance, and government relations services. The firm offers its services to the aesthetics law, automotive and motorized vehicle, aviation and aerospace, chemical, construction, energy, environmental, finance, gaming, sweepstakes and contests, healthcare, hospitality, tourism and leisure, insurance and reinsurance, manufacturing, pharmaceutical, professional services, railroad, real estate, retail, sports, technology, and transportation sectors. The company was founded by Thomas W. Wilson Sr. in 1978 and is headquartered in White Plains, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Atlanta Police Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
Hands on Atlanta
 Hands on Atlanta Services to the Health IndustryHealth Services Hands on Atlanta provides health care services. The company was founded by Deva A. Hirsch, Elise Eplan, Kent Alexander, Michelle Nunn in 1989 and is headquartered in Atlanta, GA. | Services to the Health Industry | Director/Board Member | |
Georgia Chamber of Commerce
 Georgia Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Georgia Chamber of Commerce is a chamber of commerce organization. The non-profit company is based in Atlanta, GA. The CEO of the company is Chris Clark. | Miscellaneous Commercial Services | Director/Board Member | |
Leadership Atlanta, Inc.
 Leadership Atlanta, Inc. Miscellaneous Commercial ServicesCommercial Services Leadership Atlanta, Inc. provides sustained community leadership programs. The firm specializes in leadership development, community education, relationship building and metro Atlanta. The company was founded in 1969 and is headquartered in Atlanta, GA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Tennessee | College/University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Verenigd Koninkrijk | 3 |
| Nederland | 2 |
| Frankrijk | 2 |
| Zwitserland | 2 |
Sectoraal
| Health Technology | 23 |
| Finance | 10 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 128 |
| Corporate Officer/Principal | 63 |
| Independent Dir/Board Member | 46 |
| Undergraduate Degree | 23 |
| Chairman | 15 |
Sterkste connecties
| Insiders | |
|---|---|
| Elaine Jones | 37 |
| James Rosenthal | 24 |
| Maxine Gowen | 23 |
| Michael Heffernan | 23 |
| Sara Nayeem | 23 |
| Ronald Frieson | 20 |
| Willard Dere | 16 |
| Mark Enyedy | 15 |
| Robert Copeland | 15 |
| James Ahlers | 11 |
| Jason Amello | 11 |
| Donald Bergstrom | 10 |
| Raymond T. Keane | 9 |
| LeAnne Zumwalt | 9 |
| David Noskowitz | 9 |
- Beurs
- Insiders
- David Spellman
- Bedrijfsconnecties
